ARS Pharmaceuticals, Inc.
SPRY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in ARS Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +3 vs. Q1 2024
- Shares held
- 62.6M
- +2.73M (+4.6%) vs. Q1 2024
- Total value
- $533.0M
- −$78.7M (−12.9%) vs. Q1 2024
- New holders
- 24
- 46 more added
- Sold out
- 21
- 24 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SPRY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 208 | $726.0M |
| Q1 2026 | 203 | $757.5M |
| Q4 2025 | 191 | $1.05B |
| Q3 2025 | 188 | $840.4M |
| Q2 2025 | 188 | $1.48B |
| Q1 2025 | 184 | $958.9M |
| Q4 2024 | 166 | $752.3M |
| Q3 2024 | 151 | $928.4M |
| Q2 2024 | 115 | $533.0M |
| Q1 2024 | 113 | $612.1M |
| Q4 2023 | 100 | $358.5M |
| Q3 2023 | 97 | $251.6M |
| Q2 2023 | 92 | $369.0M |
| Q1 2023 | 90 | $347.7M |
| Q4 2022 | 73 | $427.9M |
| Q3 2022 | 61 | $160.4M |
| Q2 2022 | 64 | $110.5M |
| Q1 2022 | 70 | $94.7M |
| Q4 2021 | 72 | $200.5M |
| Q3 2021 | 74 | $288.4M |
| Q2 2021 | 76 | $864.6M |
| Q1 2021 | 68 | $1.21B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding ARS Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 639,203 | $5.44M | 0.14% | 00.0% | Unchanged |
| Royce & Associates LP | 645,700 | $5.49M | 0.05% | +87,000+15.6% | Added |
| Perceptive Advisors LLC | 867,319 | $7.38M | 0.18% | 00.0% | Unchanged |
| FMR LLC | 1,085,318 | $9.24M | 0.00% | +3960.0% | Added |
| Geode Capital Management, LLC | 1,195,878 | $10.2M | 0.00% | +319,207+36.4% | Added |
| State Street Corp | 1,856,221 | $15.8M | 0.00% | +251,671+15.7% | Added |
| Nextech Invest AG | 1,910,029 | $16.3M | 2.73% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 2,461,672 | $20.9M | 4.63% | +242,541+10.9% | Added |
| Franklin Resources Inc | 2,950,963 | $25.1M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,250,927 | $27.7M | 0.00% | +364,472+12.6% | Added |
| Sr One Capital Management, LP | 4,012,903 | $34.1M | 10.69% | 00.0% | Unchanged |
| BlackRock Inc. | 4,084,339 | $34.8M | 0.00% | +1,426,100+53.6% | Added |
| OrbiMed Advisors LLC | 9,240,887 | $78.6M | 1.68% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 10,860,977 | $92.4M | 1.22% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 11,077,927 | $94.3M | 1.57% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −72,322−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −34,570−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −27,120−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,201−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −16,800−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,633−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −12,099−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,139−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −10,117−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −10,093−100.0% | Sold out |
| Salomon & Ludwin, LLC | 0 | $0 | 0.00% | −2,785−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,100−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,495−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,472−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −169−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |